Stockscreener 앱 받기
310.36
0.42%
-1.4973
전일 마감가:
$311.86
열려 있는:
$306.6
하루 거래량:
167.43K
Relative Volume:
0.58
시가총액:
$34.02B
수익:
$4.56B
순이익/손실:
$-176.77M
주가수익비율:
-180.69
EPS:
-1.7177
순현금흐름:
$225.30M
1주 성능:
-1.99%
1개월 성능:
-9.69%
6개월 성능:
+21.42%
1년 성능:
+0.00%
1일 변동 폭
$306.60
$316.80
1주일 범위
$306.60
$318.00
52주 변동 폭
$172.67
$355.30
Beone Medicines Ltd Adr Stock (ONC) Company Profile
명칭
Beone Medicines Ltd Adr
전화
41-616851900
주소
C/O BEONE MEDICINES I GMBH, BASEL
ONC을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
310.20 | 34.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.80 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.02 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
422.55 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
836.27 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
183.19 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-09-18 | 개시 | Barclays | Overweight |
| 2025-04-07 | 개시 | RBC Capital Mkts | Outperform |
| 2025-03-03 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2024-12-03 | 재개 | Morgan Stanley | Overweight |
| 2024-09-18 | 개시 | JMP Securities | Mkt Outperform |
| 2024-02-06 | 재개 | JP Morgan | Overweight |
| 2023-09-12 | 개시 | Macquarie | Outperform |
| 2023-08-17 | 개시 | Jefferies | Buy |
| 2023-07-17 | 개시 | Citigroup | Buy |
| 2023-06-30 | 다운그레이드 | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | 개시 | Daiwa Securities | Buy |
| 2022-10-13 | 업그레이드 | Guggenheim | Neutral → Buy |
| 2022-10-13 | 업그레이드 | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | 재개 | JP Morgan | Overweight |
| 2022-03-17 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | 개시 | Deutsche Bank | Buy |
| 2021-10-12 | 개시 | Bernstein | Outperform |
| 2021-10-06 | 업그레이드 | CLSA | Underperform → Buy |
| 2021-03-08 | 개시 | China Renaissance | Buy |
| 2021-03-01 | 다운그레이드 | CLSA | Outperform → Underperform |
| 2020-11-09 | 다운그레이드 | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | 다운그레이드 | Maxim Group | Buy → Hold |
| 2020-11-06 | 다운그레이드 | Piper Sandler | Neutral → Underweight |
모두보기
Beone Medicines Ltd Adr 주식(ONC)의 최신 뉴스
ETFs Investing in BeOne Medicines Ltd. Sponsored ADR Stocks - TradingView
AMGEN ANNOUNCES 2025 FOURTH QUARTER DIVIDEND - Benzinga
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Oppenheimer Asset Management Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Allianz Asset Management GmbH Acquires Shares of 3,300 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
DekaBank Deutsche Girozentrale Purchases Shares of 13,600 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Yousif Capital Management LLC Invests $368,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Sequoia Financial Advisors LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Janney Montgomery Scott LLC Takes $373,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Callan Family Office LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,002 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by IFP Advisors Inc - MarketBeat
Free cash flow per share of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
BeOne Medicines Ltd.Sponsored ADR (NASDAQ:ONC) Given Average Rating of "Moderate Buy" by Brokerages - MarketBeat
Blue Trust Inc. Buys New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
BeOne Medicines (ONC): Valuation Insight Following Positive Sonrotoclax Trial Results - Sahm
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Net income before discontinued operations of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
Operating expenses (excl. COGS) of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
BeOne Medicines (NASDAQ:ONC) SVP Sells $3,739,118.40 in Stock - MarketBeat
Venturi Wealth Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys Shares of 3,824 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd. Sponsored ADR (ONC) Stock Price Today | Live Chart & News - Traders Union
160 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Acquired by Farther Finance Advisors LLC - Defense World
Slow Capital Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Signaturefd LLC Purchases New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
PFG Investments LLC Acquires Shares of 985 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Reaches New 52-Week HighTime to Buy? - MarketBeat
14,420 Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - Defense World
14,420 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by Public Employees Retirement System of Ohio - MarketBeat
Perigon Wealth Management LLC Acquires New Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
LVW Advisors LLC Purchases Shares of 1,022 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Aaron Wealth Advisors LLC Invests $200,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Brokerages Set BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Target Price at $336.30 - Defense World
John Oyler Sells 27,803 Shares of BeOne Medicines (NASDAQ:ONC) Stock - MarketBeat
Avanza Fonder AB Makes New $199,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr (ONC) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
0.52%
자본화:
|
볼륨(24시간):